FIELD: medicine.
SUBSTANCE: invention concerns application of “Semax” peptide as agent, activating adaptive immunity for correction of immune status and elimination of imbalance inflammatory and anti-inflammatory effects in central nervous system diseases accompanied by disturbance of immune response, including stroke.
EFFECT: invention provides effect on immune system in ischemic stroke due to activation of acquired specific immunity.
1 cl, 1 ex, 3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2013 |
|
RU2672341C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULT AND METHOD FOR THERAPY | 2002 |
|
RU2251429C2 |
| HYBRID PROTEIN IGF-1-LONG FOR TREATING STROKE, NUCLEIC ACID, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 2018 |
|
RU2711111C1 |
| METHOD OF TREATING CONDITIONS ASSOCIATED WITH A FACTOR INDUCED BY HYPOXIA (HIF) | 2015 |
|
RU2686308C2 |
| METHOD FOR DETERMINING FUNCTIONAL ACTIVITY PROFILE OF RECEPTOR PEPTIDES-AGONISTS ACTIVATED BY PROTEASE TYPE 1 UNDER EXPERIMENTAL CONDITIONS IMITATING ISCHEMIC | 2020 |
|
RU2750893C1 |
| METHOD FOR MODELING FOCAL ISCHEMIC STROKE OF BRAIN | 2020 |
|
RU2756427C1 |
| AGENT WITH NEUROPROTECTIVE ACTIVITY | 2019 |
|
RU2800955C2 |
| COMPOSITIONS AND METHODS FOR TREATING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL DAMAGE | 2009 |
|
RU2501564C2 |
| METHOD OF PRODUCING GLIAL DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS WITH INCREASED EXPRESSION OF BDNF FOR THERAPY OF ISCHEMIC STROKE | 2023 |
|
RU2829361C1 |
| METHOD OF MYOCARDIUM INFARCTION TREATMENT | 2003 |
|
RU2330665C2 |
